127188-33-4 Usage
General Description
4-BOC-1-(6-Methyl-2-pyridyl)piperazine is a chemical compound with the molecular formula C16H24N4O2. It is a derivative of piperazine, a widely used building block in organic chemistry. The compound contains a BOC (tert-butoxycarbonyl) protecting group, which is commonly used to protect the amine functional group in organic synthesis. 4-BOC-1-(6-Methyl-2-pyridyl)piperazine has potential applications in pharmaceutical chemistry as a precursor for the synthesis of various bioactive compounds, particularly those targeting the central nervous system. Its structure and reactivity make it a valuable intermediate for the production of drugs and other organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 127188-33-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,7,1,8 and 8 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 127188-33:
(8*1)+(7*2)+(6*7)+(5*1)+(4*8)+(3*8)+(2*3)+(1*3)=134
134 % 10 = 4
So 127188-33-4 is a valid CAS Registry Number.
InChI:InChI=1/C15H23N3O2/c1-12-6-5-7-13(16-12)17-8-10-18(11-9-17)14(19)20-15(2,3)4/h5-7H,8-11H2,1-4H3
127188-33-4Relevant articles and documents
POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS
-
Page/Page column 92, (2018/07/29)
The present invention is related to a pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound represented by the following structural formula: The present invention is also related a method of treating a subject with a disease which can be ameliorated by inhibition of poly(ADP-ribose)polymerase (PARP). The definitions of the variables are provided herein.
Novel Aryl Piperazine Derivatives With Medical Utility
-
Page/Page column 35, (2009/10/01)
This invention provides novel aryl piperazine derivatives having medical utility, in particular as modulators of dopamine and serotonin receptors, preferably the D3, D2-like and 5-HT2 receptor subtypes, and in particular u
